Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Related Articles
A comparison of antiplatelet and oral anticoagulation strategies to prevent cerebral microembolism after transcatheter aortic valve implantation: the AUREA trial
Comparison of dual antiplatelet therapy versus oral anticoagulation to prevent cerebral embolism after transcatheter aortic valve implantation.
Predictors of pacemaker implantation in aortic regurgitation patients treated with a dedicated transcatheter heart valve
Study on permanent pacemaker implantation rates and risk factors after transcatheter aortic valve implantation for aortic regurgitation using the JenaValve Trilogy System.
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme
Comprehensive overview of interventional procedures and therapies in cardiology, including coronary, valvular, heart failure, peripheral, hypertension, and stroke interventions.
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme
Comprehensive overview of interventional procedures and therapies in cardiology, including coronary, valvular, heart failure, peripheral, hypertension, and stroke interventions.
Can a CT scan characterise and predict HALT evolution?
Study on hypoattenuated leaflet thickening (HALT) observed in TAVI patients and its association with clinical outcomes.
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial
The COMPARE STEMI ONE trial evaluates an abbreviated DAPT regimen and OCT-guided revascularization in STEMI patients undergoing PCI.
Design and rationale of PRAGUE-26: a multicentre, randomised trial of catheter-directed thrombolysis for intermediate-high risk acute pulmonary embolism
The PRAGUE-26 trial evaluates the clinical outcomes of catheter-directed thrombolysis versus standard anticoagulation in patients with intermediate-high risk acute pulmonary embolism.
Using pericoronary fat attenuation to guide management after coronary interventions
This study explores the limitations of contemporary coronary intervention strategies and the role of coronary inflammation in the natural history of atherosclerosis.